CTOs on the Move

Symbiomix Therapeutics

www.symbiomix.com

 
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.symbiomix.com
  • 105 Lock Street Suite 409
    Newark, NJ USA 07103-3576
  • Phone: 609.722.7250

Executives

Name Title Contact Details

Funding

Symbiomix Therapeutics raised $41M on 05/06/2015

Similar Companies

Mary Free Bed Rehabilitation Hospital

Mary Free Bed Rehabilitation Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mary Free Bed Rehabilitation Hospital is based in Grand Rapids, MI. You can find more information on Mary Free Bed Rehabilitation Hospital at www.maryfreebed.com

Vitaquest International

Vitaquest International is a West Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helix Medical

Helix Medical is a Carpinteria, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dako

DAKO is a fully integrated, global provider of cancer diagnostic and research products for pathology and oncology. The Company's products utilize antibodies, nucleic acid probes, and proprietary detection technologies to identify specific

Advogent

Advogent is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.